Twogee Biotech GmbH

Based in Bavaria, Germany, Twogee Biotech GmbH operates in the biotechnology sector, focusing on converting biomass into valuable materials using advanced enzymatic solutions. Twogee Biotech GmbH, founded in 2025 in Bavaria, Germany, specializes in the development of enzyme technologies for biomass conversion. As of January 29, 2026, the company completed a SEED funding round, raising EUR 2. 16 mn from investors including Bayern Kapital and High-Tech Gruenderfonds.

This was its first significant deal, aimed at enhancing its enzyme technology. The firm has no known subsidiaries or parent companies. Twogee Biotech specializes in transforming (bio-)side products and waste streams into high-value second-generation (2G) sugars and materials through advanced enzymatic solutions. The company offers a robust enzyme and strain development platform designed for producing cost-competitive, customer-specific enzymatic solutions.

By optimizing efficiency and yield, Twogee Biotech aids partners across various industries in unlocking hidden value within their materials, thereby enhancing profitability. The firm supports the transition to a circular economy by upcycling carbon from biomass to minimize waste. Key customers include businesses in biomass waste-producing sectors, primarily within Europe and North America, where there is a growing demand for eco-friendly production methods. Twogee Biotech generates revenue through strategic partnerships and licensing agreements, enabling clients to utilize its innovative enzymatic solutions and high-performance production strains.

The company typically engages in B2B arrangements, allowing businesses to acquire tailored enzymatic solutions that fit their production processes. Through these agreements, clients leverage Twogee's technology to improve production efficiency and profitability, aligning with the increasing demand for sustainable biotechnological applications across different industries. Specific pricing details for products and services are not disclosed. In January 2026, Twogee Biotech GmbH raised EUR 2.

16 mn in Seed funding, co-led by investors Bayern Kapital and High-Tech Gruenderfonds, along with participation from BayStartUP, BayWa Venture, and others. The company plans to utilize this funding to further develop its enzyme technology aimed at converting biomass into raw materials. Twogee Biotech is also targeting expansion into new markets, focusing on enhancing its presence in Europe and North America to meet rising demands for sustainable solutions.